ARKF vs XBI
ARK Fintech Innovation ETF vs SPDR S&P Biotech ETF
ARKF—
ARK Fintech Innovation ETF
Fintech companies disrupting financial services.
Expense: —Yield: —
XBI—
SPDR S&P Biotech ETF
Equal-weight biotech stocks in the S&P Biotech Index.
Expense: —Yield: —
Side-by-side metrics
| Metric | ARKF | XBI |
|---|---|---|
Expense ratio Annual fee. Lower is better. | — | — |
Dividend yield Trailing 12-month yield. | — | — |
AUM Assets under management — bigger funds are typically more liquid. | — | — |
YTD return | — | — |
1-year return | — | — |
3-year return Annualized. | — | — |
5-year return Annualized. | — | — |
10-year return Annualized. | — | — |
Beta (3Y) Volatility relative to the market. Closer to 1 = market-like. | — | — |
P/E ratio | — | — |
Last price | — | — |
Inception | — | — |
Issuer | ARK | State Street |
ARKF top holdings
Holdings data unavailable for ARKF.
XBI top holdings
Holdings data unavailable for XBI.
About ARKF
ARKF (ARK Fintech Innovation ETF) is Fintech companies disrupting financial services.
About XBI
XBI (SPDR S&P Biotech ETF) is Equal-weight biotech stocks in the S&P Biotech Index.